S&P 500   4,604.37 (+0.41%)
DOW   36,247.87 (+0.36%)
QQQ   392.17 (+0.45%)
AAPL   195.71 (+0.74%)
MSFT   374.23 (+0.88%)
META   332.75 (+1.89%)
GOOGL   134.99 (-1.42%)
AMZN   147.42 (+0.37%)
TSLA   243.84 (+0.49%)
NVDA   475.06 (+1.95%)
NIO   7.39 (-1.34%)
BABA   72.16 (-0.24%)
AMD   128.92 (+0.43%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.96 (+1.78%)
CGC   0.80 (+11.11%)
GE   120.59 (+0.93%)
DIS   92.82 (+0.84%)
AMC   6.93 (+1.61%)
PFE   28.78 (+0.52%)
PYPL   58.94 (+0.79%)
XOM   99.55 (+1.15%)
S&P 500   4,604.37 (+0.41%)
DOW   36,247.87 (+0.36%)
QQQ   392.17 (+0.45%)
AAPL   195.71 (+0.74%)
MSFT   374.23 (+0.88%)
META   332.75 (+1.89%)
GOOGL   134.99 (-1.42%)
AMZN   147.42 (+0.37%)
TSLA   243.84 (+0.49%)
NVDA   475.06 (+1.95%)
NIO   7.39 (-1.34%)
BABA   72.16 (-0.24%)
AMD   128.92 (+0.43%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.96 (+1.78%)
CGC   0.80 (+11.11%)
GE   120.59 (+0.93%)
DIS   92.82 (+0.84%)
AMC   6.93 (+1.61%)
PFE   28.78 (+0.52%)
PYPL   58.94 (+0.79%)
XOM   99.55 (+1.15%)
S&P 500   4,604.37 (+0.41%)
DOW   36,247.87 (+0.36%)
QQQ   392.17 (+0.45%)
AAPL   195.71 (+0.74%)
MSFT   374.23 (+0.88%)
META   332.75 (+1.89%)
GOOGL   134.99 (-1.42%)
AMZN   147.42 (+0.37%)
TSLA   243.84 (+0.49%)
NVDA   475.06 (+1.95%)
NIO   7.39 (-1.34%)
BABA   72.16 (-0.24%)
AMD   128.92 (+0.43%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.96 (+1.78%)
CGC   0.80 (+11.11%)
GE   120.59 (+0.93%)
DIS   92.82 (+0.84%)
AMC   6.93 (+1.61%)
PFE   28.78 (+0.52%)
PYPL   58.94 (+0.79%)
XOM   99.55 (+1.15%)
S&P 500   4,604.37 (+0.41%)
DOW   36,247.87 (+0.36%)
QQQ   392.17 (+0.45%)
AAPL   195.71 (+0.74%)
MSFT   374.23 (+0.88%)
META   332.75 (+1.89%)
GOOGL   134.99 (-1.42%)
AMZN   147.42 (+0.37%)
TSLA   243.84 (+0.49%)
NVDA   475.06 (+1.95%)
NIO   7.39 (-1.34%)
BABA   72.16 (-0.24%)
AMD   128.92 (+0.43%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.96 (+1.78%)
CGC   0.80 (+11.11%)
GE   120.59 (+0.93%)
DIS   92.82 (+0.84%)
AMC   6.93 (+1.61%)
PFE   28.78 (+0.52%)
PYPL   58.94 (+0.79%)
XOM   99.55 (+1.15%)
Negative News SentimentNegative News

Aerovate Therapeutics (AVTE) Earnings Date, Estimates & Call Transcripts

$17.04
+0.39 (+2.34%)
(As of 12/8/2023 ET)
Compare
Today's Range
$16.49
▼
$17.58
50-Day Range
$9.58
▼
$17.04
52-Week Range
$9.41
▼
$30.79
Volume
69,047 shs
Average Volume
84,398 shs
Market Capitalization
$471.50 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$42.00
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

AVTE Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AVTE Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Aerovate Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20231($0.51)($0.51)($0.51)
Q2 20231($0.63)($0.63)($0.63)
Q3 20231($0.65)($0.65)($0.65)
Q4 20231($0.68)($0.68)($0.68)
FY 20234($2.47)($2.47)($2.47)

AVTE Earnings Date and Information

Aerovate Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 3rd, 2024 based off prior year's report dates.

Aerovate Therapeutics Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
4/3/2024
Estimated)		------- 
8/14/2023Q2 2023($0.69)($0.76)($0.07)($0.76)--
5/15/2023Q1 2023($0.58)($0.67)($0.09)($0.67)--
3/29/2023Q4 2022($0.58)($0.61)($0.03)($0.61)--
11/14/2022Q3 2022($0.50)($0.56)($0.06)($0.56)--
8/15/2022Q2 2022($0.46)($0.49)($0.03)($0.49)--
5/16/2022Q1 2022($0.26)($0.45)($0.19)($0.45)--
3/30/2022Q4 2021-($0.07)($0.07)($0.07)--
11/14/2021Q3 2021($0.26)($0.26)-($0.26)--
8/15/2021Q2 2021($0.16)($23.80)($23.64)($23.80)--












Aerovate Therapeutics Earnings - Frequently Asked Questions

When is Aerovate Therapeutics's earnings date?

Aerovate Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 3rd, 2024 based off last year's report dates. Learn more on AVTE's earnings history.

How much profit does Aerovate Therapeutics generate each year?

Aerovate Therapeutics (NASDAQ:AVTE) has a recorded net income of -$51.51 million. AVTE has generated -$2.75 earnings per share over the last four quarters.

What is Aerovate Therapeutics's EPS forecast for next year?

Aerovate Therapeutics's earnings are expected to grow from ($2.85) per share to ($2.74) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:AVTE) was last updated on 12/8/2023 by MarketBeat.com Staff

My Account -